Functional assays confirmed that SLC12A7 enhances HCC cell proliferation, migration, and invasion.<h4>Conclusions</h4>These findings identify SLC12A7 as a potential prognostic biomarker and immunotherapeutic target across cancers. This evidence concerns the gene SLC12A7 and hepatocellular carcinoma.